The Not-So-Silk Road: The Proliferating Regulatory Obstacles to Chinese Investment in the U.S.

All companies engaged in M&A activity in the United States must plan for enhanced scrutiny from an increasingly aggressive DOJ and FTC, but non-U.S. companies, particularly Chinese companies, must also reckon with another U.S. regulatory regime with the power to scuttle their deals: the Committee on Foreign Investment in the United States, or CFIUS. CFIUS is a U.S. interagency body that assesses the risk to national security of transactions involving non-U.S. acquirers. Coincident with the t